Novo Nordisk announced that the FDA has approved a 2.0 mg dose of Ozempic® a glucagon-like peptide-1 analogue for the treatment of adults with type 2 diabetes.
[Full Journal Title]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Pancreatic Cell News Ozempic® 2.0 mg Approved in the US for the Treatment of Type...
